drugset / Trial / NCT02119754
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Phase 2
Completed
15 enrolled
PluroGen Therapeutics, Inc
Arkios BioDevelopment International · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open label study of subjects who have failed Protocol PGN-1300. Adult subjects (greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis but not involving joint capsule, tendon, and bone) and have failed PGN-1300. Subjects must also provide informed consent and meet all other entry criteria to be enrolled and receive PluroGel PN.
Timeline
- Start
- 2013-10
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plurogel PN | Unknown | — | Topical |